|
Product complaint # (b)(4).Complainant part is expected to be returned for manufacturer review/investigation but has yet to be received.A manufacturing record evaluation was performed for the finished article lot and no non-conformances were identified.The investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Device report from synthes reports an event in the usa as follows: it was reported that on (b)(6) 2022, while the surgeon was performing an im nail of a femur using the lateral entry femoral nail.As the surgeon was rotating the aiming arm for the nail it broke loose.After realizing the aiming arm was no longer securely attached to the femoral nail, the surgeon had to perform a perfect circle technique to place his proximal locking screws.There was 5 minutes of surgical delay.Fragments were generated but were removed without additional intervention.There was no patient outcome.Concomitant device reported: unk - nails: femoral (part# unknown; lot# unknown; quantity: unknown).This complaint involves one (1) device percutaneous insertion handle.This is report 1 of 1 for complaint (b)(4).
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H3, h6: a product investigation was conducted.The product was returned to depuy synthes for evaluation.The depuy synthes team conducted a visual inspection of the returned device.Visual analysis of the returned sample revealed that percutaneous insertion handle (product code: 03.010.046 lot number: l929339) appears to be broken off from the tang, fragment was not returned.No other issues were found.A dimensional inspection was unable to be performed due to post-manufacturing damage.The observed condition of the device was consistent with a random component failure that may have been caused by exposure to unintended forces.As part of depuy synthes quality process, all devices are manufactured, inspected, and released to approved specifications.The overall complaint was confirmed for percutaneous insertion handle (product code: 03.010.046 lot number: l929339) as the observed condition contribute to the complained device issue.There is no indication that a design or manufacturing issue has caused the complaint condition and hence the root cause cannot be determined.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.H6: photo investigation: the photo was returned to depuy synthes for evaluation.Visual analysis of the photo revealed that the percutaneous insertion handle appears to have broken off from the tang, fragment is not visible in the evidence provided.H3, h6: a device history record (dhr) review was conducted: part # 03.010.046-us lot # l929339 manufacturing site: werk hagendorf release to warehouse date: 13 nov2018 a manufacturing record evaluation was performed for the finished article lot and no non-conformances were identified.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|